STAT Plus Pharmalittle FDA plans concierge service for expanded access to cancer meds; Novartis anchored gene therapy price

STAT Plus: Pharmalittle: FDA plans ‘concierge service’ for expanded access to cancer meds; Novartis ‘anchored’ gene therapy price

Sometimes, sorting out how to price a new drug is like determining the number of ping pong balls needed to fill the Empire State Building.

More From BioPortfolio on "STAT Plus: Pharmalittle: FDA plans ‘concierge service’ for expanded access to cancer meds; Novartis ‘anchored’ gene therapy price"